Achillion Pharmaceuticals — Merger or Acquisition (November 2019)
23 slides from Achillion Pharmaceuticals's merger presentation, Nov 20, 2019
Slide 1: Alexion / Achillion Acquisition: Overview of Equity Impact
©2019 Achillion Pharmaceuticals. All rights reserved. Alexion / Achillion Acquisition NASDAQ:ACHN Overview of Equity Impact
Slide 2: Discussion Topics
Discussion Topics Strategic Transaction Context What will happen to my stock options from now until completion of the transaction (“Closing”)? Provide an understanding of how your options are impacted upon Closing What’s vested and unvested? Options vesting at Closing Options at CVR milestones What’
Slide 3: Transaction Overview
Transaction Overview Value Transaction valued up to $1.2 billion Consideration $6.30 per share in cash and a non-tradeable Contingent Value Right (CVR) CVR entitles shareholders to receive $1.00 per share for FDA approval of danicopan within 54 months of Closing of the transaction and $1.00 per shar
Slide 4: What is a CVR?
What is a CVR? A Contingent Value Right, or CVR, allows shareholders to receive additional payment if a certain event occurs Upon Closing, Achillion shareholders will receive: $6.30 per share in cash and a non-tradeable Contingent Value Right (CVR), which may be paid to Achillion shareholders if cer
Slide 5: What will happen to my stock options from now until Closing?
What will happen to my stock options from now until Closing? Important information that you need to understand: What will happen to my stock options from now until Closing? No impact. They will continue to vest according to our normal vesting schedule: 25% vesting after one year of grant date; 6.25%
Slide 6: What is a Stock Option?
What is a Stock Option? What is Stock Option? A stock option is the right to purchase shares of Achillion stock at a specified purchase price (the “Grant Price”). Achillion stock options vest over time, subject to continued employment – 25% vests at the one-year anniversary of the date of grant of t
Slide 7: What is a Stock Option? (cont'd)
What is a Stock Option? (cont’d) “In the Money” Options: Stock options that have a Grant Price lower than $6.30 are considered “In the Money”. At Closing, the purchase price for Achillion Stock will be $6.30. If the Grant Price of your stock option was $2.25, that option would be “In the Money”; $6.
Slide 8: Understanding Your Equity Holdings: How many options do I have?
Understanding Your Equity Holdings: How many options do I have? What is vested and unvested? Employee Shareworks: Log onto Sharework portal to view your equity history. www.Shareworks.com Shareworks -> Portfolio View provides the following information on your equity grants: Grant Price # of Options
Slide 9: Illustrative Example: Vesting as of 2/28/20
Illustrative Example: Vesting as of 2/28/20, Assumes Closing on 3/1/2020 Vesting as of February 28, 2020 Grant Date Options Granted Type of Option Grant Price Unvested Options Vested Options Total Options Outstanding (# of Unexercised Options) 4-Dec-14 10,000 NQ $ 13.80 - 10,000 10,000 25-Jan-16 10,
Slide 10: Illustrative Equity Walkthrough - Assumes Closing Date 3/1/20
Illustrative Equity Walkthrough - Assumes Closing Date: 3/1/20 At the Closing Date: ALL unvested options will vest if you have executed and not revoked either a General Release Agreement or a Non-Competition Agreement, as applicable The value you will receive for your Stock Options is calculated by:
Slide 11: Illustrative Equity Walkthrough – Achievement of CVR milestone
Illustrative Equity Walkthrough – Achievement of 1 CVR milestone Upon achievement of key future milestones all shareholders will be entitled to receive a $1.00 CVR for each share held. Reminder: CVRs are contingent future payments. They are NOT guaranteed. CVRs: If your stock options are “In The Mon
Slide 12: Illustrative Equity Walkthrough – Achievement of both CVR milestones
Illustrative Equity Walkthrough – Achievement of both CVR milestones If the second CVR milestone is reached, all holders of In the Money options and holders of Out of the Money options with a Grant Price of less than $8.30 will be entitled to another $1 CVR per share of stock. Reminder: CVRs are con
Slide 13: Employee Stock Purchase Plan (ESPP): Where can I review my shares?
I have participated in Achillion’s Employee Stock Purchase Plan (ESPP) - Where can I review my shares? What happens next? Historical ESPP purchases You are able to view your ESPP purchase history through the Shareworks Equity Portal, www.Shareworks.com Notes regarding past participation: In the past
Slide 14: How will ESPP stock be treated at Closing? What about CVRs?
How will stock purchased through Achillion’s ESPP be treated at Closing? What about CVRs? In respect of any shares of Achillion stock you own at Closing including stock purchased through Achillion’s ESPP, you will receive: $ 6.30 for each share of stock, and 1 Contingent Value Right (CVR) for each s
Slide 15: When can I make transactions from now until Closing?
When can I make transactions from now until Closing? Achillion is currently in a blackout period. Any equity transactions are prohibited with two exceptions: Transactions under a 10b5-1 plan with Morgan Stanley Cash exercise of a stock option on the expiration date NOTE: You may exercise stock optio
Slide 16: How do I access my Stock Options Account?
How do I access my Stock Options Account? Shareworks – Equity Portal You can access your stock option / equity information through the Shareworks Equity Portal www.Shareworks.com Provides visibility into your stock option grants; including individual grant amounts, option price, vesting, etc. Also p
Slide 17: Shareworks Equity Portal – Dashboard
Shareworks Equity Portal – Dashboard This is the Dashboard screen for the employee portal – Notification of any tasks that may require your attention Overview of your stock options Overview of recent/pending vesting activity Links to other areas of the Shareworks portal Total Portfolio Value – Repre
Slide 18: Shareworks Equity Portal – Viewing Your ESPP History
Shareworks Equity Portal – Viewing Your Employee Stock Purchase Plan (ESPP) History In addition to the overview of your stock option grant history, Shareworks also provides an overview of your purchase history through Achillion’s ESPP To access your ESPP information in Shareworks go to: Shareworks -
Slide 19: Shareworks Equity Portal – Viewing Your ESPP History (continued)
Shareworks Equity Portal – Viewing Your Employee Stock Purchase Plan (ESPP) History (continued) The Fund Details provide an overview of your historical ESPP plan purchases and any shares purchased from the ESPP plan period which ended on May 31, 2019. Shares listed with a Purchase Date BEFORE May 31
Slide 20: Disclosures
Disclosures This document constitutes part of a prospectus covering securities that have been registered under the Securities Act of 1933, as amended. For additional details related to the Achillion Pharmaceuticals, Inc. Amended and Restated 2015 Stock Incentive Plan and the 2006 Employee Stock Ince
Slide 21: Forward Looking Statements
Forward Looking Statements The information contained in this document is as of the date of the presentation. Achillion assumes no obligation to update forward-looking statements contained in this document as the result of new information or future events or developments. This document contains forwa
Slide 22: Note to Investors and Security Holders
Note to Investors and Security Holders This document does not constitute a solicitation of any vote or approval. In connection with the proposed acquisition of Achillion by Alexion, Achillion intends to file with the SEC a definitive proxy statement, as well as other relevant documents concerning th
Slide 23: Certain Information Regarding Participants
Certain Information Regarding Participants Alexion, Achillion and their respective directors and executive officers may be considered participants in the solicitation of proxies in connection with the proposed transaction. Information about the directors and executive officers of Alexion is set fort
Achillion Pharmaceuticals — Merger or Acquisition (November 2019) on 6ix